Paper · 41369591
Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression.
Triolo TM and 15 others. Diabetes, 2026. Cited by 3 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Type 2 Diabetes Genetic Risk and Type 1 Diabetes Heterogeneity and Progression. Papers, record 41369591. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41369591
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus, Type 1 | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Genetic Predisposition to Disease | Major topic |
| Humans | |
| Disease Progression | |
| C-Peptide | |
| Female | |
| Male | |
| Adult | |
| Autoantibodies | |
| Polymorphism, Single Nucleotide | |
| Insulin Secretion | |
| Middle Aged | |
| Risk Factors | |
| Insulin-Secreting Cells | |
| Insulin |
Source PubMed
Grants27
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U01 DK061010 | NIDDK NIH HHS | United States | U01DK061010 | PubMed | NIH RePORTER |
| U01 DK085453 | NIDDK NIH HHS | United States | U01DK085453 | PubMed | NIH RePORTER |
| U01 DK106993 | NIDDK NIH HHS | United States | U01DK106993 | PubMed | NIH RePORTER |
| U01 DK103282 | NIDDK NIH HHS | United States | U01DK103282 | PubMed | NIH RePORTER |
| UC4 DK106993 | NIDDK NIH HHS | United States | UC4DK106993 | PubMed | NIH RePORTER |
| U01 DK061042 | NIDDK NIH HHS | United States | U01DK061042 | PubMed | NIH RePORTER |
| U01 DK085509 | NIDDK NIH HHS | United States | U01DK085509 | PubMed | NIH RePORTER |
| UC4 DK117009 | NIDDK NIH HHS | United States | UC4DK117009 | PubMed | NIH RePORTER |
| UC4 DK117009-01 | Eunice Kennedy Shriver National Institute of Child Health and Human Development | UC4DK117009 | PubMed | NIH RePORTER | |
| U01 DK085476 | NIDDK NIH HHS | United States | U01DK085476 | PubMed | NIH RePORTER |
1 to 10 of 27
See all 27 grantsTrials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37,804,855 | Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes. | Lancet Diabetes Endocrinol | 2023 | https://conductscience.org/library/papers/37804855 | PubMed |
| 2 | 19,120,262 | Type 1 Diabetes TrialNet--an international collaborative clinical trials network. | Ann N Y Acad Sci | 2008 | https://conductscience.org/library/papers/19120262 | PubMed |
| 3 | 30,655,379 | Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis. | Diabetes Care | 2019 | https://conductscience.org/library/papers/30655379 | PubMed |
| 4 | 36,282,337 | Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants. | Diabetologia | 2023 | https://conductscience.org/library/papers/36282337 | PubMed |
| 5 | 37,337,007 | Heterogeneity and endotypes in type 1 diabetes mellitus. | Nat Rev Endocrinol | 2023 | https://conductscience.org/library/papers/37337007 | PubMed |
| 6 | 32,770,166 | A combined risk score enhances prediction of type 1 diabetes among susceptible children. | Nat Med | 2020 | https://conductscience.org/library/papers/32770166 | PubMed |
| 7 | 27,456,836 | Do Electrochemiluminescence Assays Improve Prediction of Time to Type 1 Diabetes in Autoantibody-Positive TrialNet Subjects? | Diabetes Care | 2016 | https://conductscience.org/library/papers/27456836 | PubMed |
| 8 | 32,641,373 | Hierarchical Order of Distinct Autoantibody Spreading and Progression to Type 1 Diabetes in the TEDDY Study. | Diabetes Care | 2020 | https://conductscience.org/library/papers/32641373 | PubMed |
| 9 | 31,180,194 | An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31180194 | PubMed |
| 10 | 29,025,879 | TCF7L2 Genetic Variants Contribute to Phenotypic Heterogeneity of Type 1 Diabetes. | Diabetes Care | 2018 | https://conductscience.org/library/papers/29025879 | PubMed |
1 to 10 of 41
See all 41 referencesCited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,461,847 | BMI Normalization Is Associated With Lower Risk of Progression to Type 1 Diabetes, Primarily in Youth. | Diabetes Care | 2026 | https://conductscience.org/library/papers/42461847 | PubMed |
| 42,112,402 | Stress-driven remodeling of antigen presentation and chemokine signaling in pancreatic β-cells: implications for type 1 diabetes. | Front Immunol | 2026 | https://conductscience.org/library/papers/42112402 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| INS | 3,630 | PubTator's text mining | https://conductscience.org/library/genes/3630 |
Source NCBI Gene
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41369591
GET https://conductscience.org/api/papers/v1/41369591/grants?page=2